5 November 2015
The objective of this trial was to increase the proportion of patients responding to neoadjuvant therapy by simultaneously delivering the adjuvant chemotherapy before TME and lengthening the interval from the initiation of CRT to TMEJorge Marcet's short paper presentation at Tripartite 2014
Download